All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 139 of 206 pages ‹ First < 137 138 139 140 141 > Last ›
HSL203
Taylor , H .
The Drug Price Battle Continues : Politicians will try to cool public opinion as voters steam over drug prices.
Pharmaceutical Executive 2004 Feb 20
HSL202
De Vries, R .
Buying ethics
The Guardian Weekly 2004 Feb 19
HSL201
Vaughan , M .
Grassley Says Australia Drug Provision Intrudes On Hill Debate
CongressDaily 2004 Feb 18
HSL119
Moore , P .
From coloured tabs to computerized signals: How Canada tracks dangerous drugs
CBC News 2004 Feb 17
http://www.cbc.ca/news/adr/
HSL120
Faint Warning Generation Rx
CBS news 2004 Feb 17
http://www.cbc.ca/disclosure/archives/040217_adr/resources.html
HSL167
Garland EJ.
Facing the evidence: antidepressant treatment in children and adolescents.
CMAJ 2004 Feb 17;170:(4):489-91
http://www.cmaj.ca/cgi/content/full/170/4/489
HSL178
Hirsch L.
Randomized clinical trials: what gets published, and when?
CMAJ 2004 Feb 17;170:(4):481-3
http://www.cmaj.ca/cgi/content/full/170/4/481
HSL198
Branswell H .
Suppressed data from negative drug trials distorts science: Journal
Canadian Press 2004 Feb 17
HSL199
Mickleburgh , R .
Antidepressants found ineffective on teenagers
Globe and Mail 2004 Feb 17
HSL1785
Bhandari M, Busse JW, Jackowski D, Montori VM, Schunemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ.
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
CMAJ 2004 Feb 17;170:(4):477-80
http://www.cmaj.ca/cgi/content/full/170/4/477
HSL10211
Sharp increase in children hurt by prescription drugs
CBC News 2004 Feb 17
http://www.cbc.ca/news/story/2004/02/17/drug_reaction040217.html
HSL19514
Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ
Association between industry funding and pro-industry findings in randomized trials
CMAJ 2004 Feb 17;170:(4):477
http://www.cmaj.ca/cgi/content/abstract/170/4/477
HSL20208
Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ
Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials
CMAJ 2004 Feb 17;170:(4):
http://www.cmaj.ca/content/170/4/477.full
HSL117
Holladay , R .
Student's suicide cries out to FDA for drug warnings
Indianapolis Star 2004 Feb 15
HSL118
Dickey , F .
Physician and Author Jay Cohen Says Pharmaceutical Companies Are Endangering Lives by Recommending Drug Doses That Are Too High for Many Patients
The LA Times 2004 Feb 15
HSL183
Moynihan R.
Controversial disease dropped from Prozac product information.
BMJ 2004 Feb 14;328:(7436):365
http://bmj.bmjjournals.com/cgi/content/full/328/7436/365
HSL184
Ford N, Wilson D, Bunjumnong O, von Schoen Angerer T.
The role of civil society in protecting public health over commercial interests: lessons from Thailand.
Lancet 2004 Feb 14;363:(9408):560-3
http://web.archive.org/web/20040826051217/http://www.thelancet.com/journal/vol363/iss9408/full/llan.363.9408.editorial_and_review.28749.1
HSL9763
Walley T, Folino-Gallo P, Schwabe U, van Ganse E; EuroMedStat group.
Variations and increase in use of statins across Europe: data from administrative databases.
BMJ 2004 Feb 14;328:(7436):385-6
http://www.bmj.com/cgi/content/full/328/7436/385
HSL19820
Lenzer J
Cochrne proposes further limits on commercial funding
BMJ 2004 Feb 14;366:
http://www.bmj.com/content/328/7436/366.1.full
HSL116
Naedele , W.f
19 quit Lilly drug trial after a death
Philadelphia Inquirer 2004 Feb 13
HSL115
Wall J.K
Death fuels fallout in drug trial: 20% of patients exit Lilly's study for duloxetine after girl's suicide
Indianapolis Star 2004 Feb 12
HSL114
One in Four Americans Discuss Costs of Medicines With Doctor
Wall Street Journal 2004 Feb 11
HSL113
Women In Government Announces Partnership With Bristol-Myers Squibb Foundation to Convene First Ever Summit of State Offices of Women's Health
Yahoo News 2004 Feb 10
HSL5082
Kramer TA.
A plea for biased information.
MedGenMed 2004 Feb 10;6:(1):31
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15208543
HSL111
Lemonick , M. D
Prescription For Suicide? British authorities say some antidepressants can be deadly for kids. Now the FDA is investigating
Time Magazine 2004 Feb 9
HSL112
Wall JK
Woman participating in Lilly trial hangs self: Coroner will examine whether experimental drug played possible part in19-year-old's suicide.
The Indy Star 2004 Feb 9
HSL186
Goulding MR.
Inappropriate medication prescribing for elderly ambulatory care patients.
Arch Intern Med 2004 Feb 9;164:(3):305-12
http://archinte.ama-assn.org/cgi/content/full/164/3/305
HSL109
Sellar D.
Cancer group has Big Pharma roots
Toronto Star 2004 Feb 7
HSL110
Willcocks P.
Health care consumers need a voice
Vancouver Sun 2004 Feb 7
HSL187
Gibson L.
Spanish drug editor wins case brought by Merck, Sharp Dohme.
BMJ 2004 Feb 7;328:(7435):307
http://bmj.bmjjournals.com/cgi/content/full/328/7435/307-b
HSL188
Moynihan R.
FDA advisory panel calls for suicide warnings over new antidepressants.
BMJ 2004 Feb 7;328:(7435):303
http://bmj.bmjjournals.com/cgi/content/full/328/7435/303-a
HSL189
Moynihan R.
Drug company targets US state health officials.
BMJ 2004 Feb 7;328:(7435):306
http://bmj.bmjjournals.com/cgi/content/full/328/7435/306
HSL19754
Croft P
Constructing RSI: Belief and Desire
BMJ 2004 Feb 7;328:(354):
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC338153/
HSL4474
Ong A, Mansfield PR.
Controversies: Should free drug samples be banned?
Australian Doctor Weekly 2004 Feb 6
HSL190
Mello MM, Studdert DM, Brennan TA.
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.
N Engl J Med 2004 Feb 5;350:(6):608-13
http://content.nejm.org/cgi/content/full/350/6/608
HSL17973
Elliot S
Proposed Changes to Ad Rules
The New York Times 2004 Feb 5
HSL106
Antidepressants May Cause Suicides
The New York Times 2004 Feb 4
HSL107
Landrigan K .
State may limit gifts from drug companies
Nashua Telegraph 2004 Feb 4
HSL108
Wahlberg D.
Advertisers probe brains, raise fears
The Atlanta Journal-Constitution 2004 Feb 4
HSL102
Vedantam , S .
FDA Links Antidepressants, Youth Suicide Risk
Washington Post 2004 Feb 3
http://www.washingtonpost.com/ac2/wp-dyn?pagename=article&contentId=A7008-2004Feb2¬Found=true
HSL103
Roner L .
A matter of trust
Eye For Pharma 2004 Feb 3
http://social.eyeforpharma.com/story/matter-trust
HSL104
Boseley S.
Company 'held back' data on drug for children: Antidepressant had no effect, leak reveals
The Guardian 2004 Feb 3
http://www.guardian.co.uk/science/2004/feb/03/sciencenews.highereducation
HSL105
Lawmaker Seeks Data on Antidepressants for Kids
Reuters 2004 Feb 3
HSL191
Morgan S.
Sources of variation in provincial drug spending.
CMAJ 2004 Feb 3;170:(3):329-30
http://www.cmaj.ca/cgi/content/full/170/3/329
HSL19045
Schwartz LM, Woloshin S.
The media matter: a call for straightforward medical reporting.
Ann Intern Med 2004 Feb 3;140:(3):226-8
http://www.ncbi.nlm.nih.gov/pubmed/14757622
HSL101
Clarke , T .
U.S. Probe Into Antidepressant Drug Makers Widens
Reuters 2004 Feb 2
HSL9780
Nelson MR.
Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
Med J Aust 2004 Feb 2;180:(3):140
http://www.mja.com.au/public/issues/180_03_020204/letters_020204_fm-3.html
HSL9781
Gijsbers AJ, Whelan G.
E-drug deals: part of the Wild West world of e-commerce.
Med J Aust 2004 Feb 2;180:(3):103-4
http://www.mja.com.au/public/issues/180_03_020204/gij10849_fm-1.html
HSL14668
Barlett DL, Steele JB, Karmatz L, Kiviat B, Levinstein J.
Why We Pay So Much for Drugs
Time 2004 Feb 2
http://www.time.com/time/magazine/article/0,9171,993223-1,00.html
HSL98
Seaman B.
Is This Any Way To Have a Baby
Oprah magazine 2004 Feb 1
HSL99
Petersen , M .
Making Drugs, Shaping the Rules
The New York Times 2004 Feb 1
http://www.nytimes.com/2004/02/01/business/making-drugs-shaping-the-rules.html
HSL100
Kendall J.
Talking back to Prozac
The Boston Globe 2004 Feb 1
http://www.boston.com/news/globe/ideas/articles/2004/02/01/talking_back_to_prozac/
HSL2394
Sleight P.
Where are clinical trials going? Society and clinical trials
Journal of Internal Medicine 2004 Feb 01;255:151
http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-2796.2003.01294.x
HSL2395
Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA.
Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting.
Am J Health Syst Pharm 2004 Feb 1;61:(3):267-72
http://www.ajhp.org/cgi/reprint/61/3/267
HSL185
Metzl JM, Angel J.
Assessing the impact of SSRI antidepressants on popular notions of women's depressive illness.
Soc Sci Med 2004 Feb;58:(3):577-84
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-497YSNG-
HSL197
Faint Warning Archives
CBC News 2004 Feb
HSL514
Schafer A.
Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy.
J Med Ethics 2004 Feb;30:(1):8-24
http://jme.bmjjournals.com/cgi/content/full/30/1/8
HSL1171
Drug costs: research and development costs: the great illusion
Prescrire Int 2004 Feb;13:(69):32-6
HSL1786
Berman A.
Reducing medication errors through naming, labeling, and packaging.
J Med Syst 2004 Feb;28:(1):9-29
HSL1788
Baylis F.
The Olivieri debacle: where were the heroes of bioethics?
J Med Ethics 2004 Feb;30:(1):44-9
http://jme.bmjjournals.com/cgi/content/full/30/1/44
HSL2392
Ferris LE, Singer PA, Naylor CD.
Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto.
J Med Ethics 2004 Feb;30:(1):25-9
http://jme.bmjjournals.com/cgi/content/full/30/1/25
HSL2393
Holmes DR Jr, Firth BG, James A, Winslow R, Hodgson PK, Gamble GL, Popp RL, Harrington RA.
Conflict of interest
Am Heart J 2004 Feb;147:(2):228-37
HSL4631
Moss F, Thomson R.
A new structure for quality improvement reports.
Qual Saf Health Care 2004 Feb;13:(1):6-7
http://qhc.bmjjournals.com/cgi/content/full/13/1/6?maxtoshow=&HITS=10&hits=1
HSL9686
Petersen E.
Malaria chemoprophylaxis: when should we use it and what are the options?
Expert Rev Anti Infect Ther 2004 Feb;2:(1):119-32
HSL9784
Fung CH, Woo HE, Asch SM.
Controversies and legal issues of prescribing and dispensing medications using the Internet.
Mayo Clin Proc 2004 Feb;79:(2):188-94
HSL97
Ives N .
Study from an F.D.A. critic argues that the agency is slow to police misleading pharmaceutical ads.
The New York Times 2004 Jan 30
http://www.nytimes.com/2004/01/30/business/media-business-advertising-study-fda-critic-argues-that-agency-slow-police.html?scp=99&sq=&st=nyt&pagewanted=print?pagewanted=all
HSL93
Vedantam , S .
Antidepressant Makers Withhold Data on Children
The Washington Post 2004 Jan 29
HSL94
Cassels , A .
Pressure to use newer, pricier drugs can give taxpayers heartburn
The Vancouver Sun 2004 Jan 29
HSL95
Siig , M .
Life After Lipitor: Is Pfizer product a quick fix or dangerous drug? Residents experience adverse reactions
Tahoe World 2004 Jan 29
HSL96
Vatican condemns Aids drug firms
BBC News 2004 Jan 29
http://news.bbc.co.uk/2/hi/europe/3442217.stm
HSL4475
Richards D.
Guess who’s coming to dinner
Australian Doctor Weekly 2004 Jan 29
HSL92
Swartz S.
FDA Big Factor Behind High US Drug Costs
Reuters 2004 Jan 28
http://www.biotechblog.com/2004/01/30/107549363617383245/
HSL91
Japsen B.
Ex-TAP sales manager found guilty: 1st to go to trial in Lupron probe
Chicago Tribune 2004 Jan 27
http://articles.chicagotribune.com/2004-01-27/business/0401270256_1_astrazeneca-plc-lupron-lahey-clinic
HSL90
Why Are Drugs So Expensive?
The American Progress Report 2004 Jan 26
HSL88
Critser G.
Truth: a Bitter Pill for Drug Makers
The LA Times 2004 Jan 25
http://articles.latimes.com/2004/jan/25/opinion/op-critser25
HSL89
Barnett A .
Revealed: how stars were hijacked to boost health company's profits
The Observer 2004 Jan 25
http://www.guardian.co.uk/uk/2004/jan/25/society.research
HSL86
Harris , G AND, M .
F.D.A. Begins Push to End Drug Imports
New York Times 2004 Jan 24
http://www.nytimes.com/2004/01/24/business/24mail.html?pagewanted=1
HSL87
Walsh , B .
Tauzin turns down Hollywood but weighs new offer: Drug industry may be wooing 13-term congressman
The Times 2004 Jan 24
HSL83
Studwell , J .
Oh, behave!
Financial Times 2004 Jan 23
HSL84
Shapiro D.
Drug Companies Get Too Close for Med School's Comfort
The New York Times 2004 Jan 20
http://query.nytimes.com/gst/fullpage.html?sec=health&res=9F00E2D81439F933A15752C0A9629C8B63
HSL9787
Jacka M.
Mercenary hypocrisy at CMAJ.
CMAJ 2004 Jan 20;170:(2):174
http://www.cmaj.ca/cgi/content/full/170/2/174-a
HSL2391
Jorgensen KJ, Gotzsche PC.
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study.
BMJ 2004 Jan 17;328:(7432):148
http://bmj.bmjjournals.com/cgi/content/full/328/7432/148
HSL193
Lee TH.
"Me-Too" Products — Friend or Foe?
N Engl J Med 2004 Jan 15;350:(3):211-2
http://content.nejm.org/cgi/content/full/350/3/211
HSL3706
Burton B.
New Zealand moves to ban direct advertising of drugs.
BMJ 2004 Jan 10;328:(7431):68
http://bmj.bmjjournals.com/cgi/content/full/328/7431/68-c
HSL9876
Hern JC.
Prescribing and dispensing of veterinary medicines.
Vet Rec 2004 Jan 10;154:(2):60
HSL85
Pignarre P.
Health insurance: the bitter American lesson,
LE MONDE 2004 Jan 8
HSL2338
Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J.
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.
JAMA 2004 Jan 7;291:(1):54-62
http://jama.ama-assn.org/cgi/content/full/291/1/54
HSL9884
DeMaria AN.
Drug reimportation: sitting in the middle.
J Am Coll Cardiol 2004 Jan 7;43:(1):149-50
http://linkinghub.elsevier.com/retrieve/pii/S0735109703014219
HSL9885
Austin PC, Mamdani MM, Tu K, Zwarenstein M.
Changes in prescribing patterns following publication of the ALLHAT trial.
JAMA 2004 Jan 7;291:(1):44-5
http://jama.ama-assn.org/cgi/content/full/291/1/44
HSL1002
Gormley M.
Pfizer Settles Over Kids' Antibiotic Ads
Associated Press 2004 Jan 6
HSL1147
Woloshin S, Schwartz LM, Welch HG.
The value of benefit data in direct-to-consumer drug ads.
Health Aff (Millwood) 2004 Jan-Jun;Suppl Web Exclusives:W4-234-45
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.234v1
HSL1691
Cialdini RB, Goldstein NJ.
Social influence: compliance and conformity.
Annu Rev Psychol 2004;55:591-621
http://arjournals.annualreviews.org/doi/abs/10.1146%2Fannurev.psych.55.090902.142015?cookieSet=1
HSL5316
Bell DS, Cretin S, Marken RS, Landman AB.
A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.
J Am Med Inform Assoc 2004 Jan-Feb 01;11:(1):60-70
http://www.jamia.org/cgi/content/full/11/1/60
HSL20191
Glatter J
Promotion, Information and Advertising: Why Increasingly Blurred Boundaries do not Benefit the Public
Journal of Generic Medicines 2004 Jan 1;1:(2):128-136
http://jgm.sagepub.com/content/1/2/128.abstract
HSL194
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship.
J Am Board Fam Pract 2004 Jan;17:(1):6-18
http://www.jabfp.org/cgi/content/full/17/1/6
HSL356
Svensson S, Mansfield PR.
Escitalopram: superior to citalopram or a chiral chimera?
Psychother Psychosom 2004 Jan-Feb;73:(1):10-6
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=PPS2004073001010
HSL1138
Zoorob R, Larzelere M.
Gifts to physicians from the pharmaceutical and medical manufacturing industry: what every physician should know.
J La State Med Soc 2004 Jan-Feb;156:(1):28-32
HSL1150
Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S.
Physicians report on patient encounters involving direct-to-consumer advertising.
Health Aff (Millwood) 2004 Jan-Jun;Supplment Web Exclus:W4-219-33
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.219v1
HSL1155
Waxman HA.
Ensuring that consumers receive appropriate information from drug ads: what is the FDA's role?
Health Aff (Millwood) 2004 Jan-Jun;Supplment Web Exclus:W4-256-8
http://content.healthaffairs.org/cgi/reprint/hlthaff.w4.256v1
HSL1167
Sumpradit N, Ascione FJ, Bagozzi RP.
A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising.
Clin Ther 2004 Jan;26:(1):135-54
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRS-4BSW890-G&_coverDate=01%2F31%2F2004&_alid=272329699&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=6242&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=350cd528415b79ed8f6c00a62cff3cde
Page 139 of 206 pages ‹ First < 137 138 139 140 141 > Last ›
